News
Trump administration eyes Medicare and Medicaid coverage for weight loss drugs like Wegovy and Ozempic in a five-year pilot ...
Novo Nordisk’s Wegovy faces sharp decline in growth forecasts and share value as competition intensifies and compounded drug ...
Novo Nordisk is misunderstood by the market, creating a rare asymmetric value opportunity. Read why I rate NVO stock a Buy ...
Janus Henderson highlights strong Q2 gains led by AI and industrials. Explore how contrarian stock picks can help diversify and strengthen your portfolio.
Online weight-loss company Noom said on Monday it would sell copies of Novo Nordisk's Wegovy at an introductory price of $119 for up to a quarter of the branded drug's standard dose, giving patients a ...
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...
Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa ...
More than 160 people working at a Market Basket in New Bedford, Massachusetts, are unauthorized to work in the United States, which led to the suspension of 47 employees, the ...
The New Hampshire Department of Environmental Services (NHDES) is calling for an Air Quality Action Day and advising sensitive groups across the state to limit time spent outdoors Monday, citing ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results